Ocular Surface Disease

Upsher-Smith launched generic cyclosporine ophthalmic emulsion 0.05% in the US for tear production in inflammatory dry eye.

NUS researchers report that plant-based photosynthetic nanoparticles restored corneal NADPH levels and reversed damage within 5 days in preclinical dry eye.

Knowing the shared signs and symptoms can lead to proper diagnosis.

The study demonstrates that Corynebacterium mastitidis, a bacterium that resides on the ocular surface, can be genetically modified to secrete the anti-inflammatory cytokine interleukin-10.

Sex hormones play important but distinct roles in regulating the ocular surface and adnexal tissues.

For many patients with mild to moderate allergic conjunctivitis, OTC ophthalmic medications can provide effective relief.

The study highlights the broader impact of OR on patients’ quality of life.

Amniotic membrane therapy has been used in refractory cases to protect the ocular surface, modulate inflammation and fibrosis, and promote epithelial healing.

The review notes aesthetic considerations are increasingly important as social media and video conferencing spotlight facial appearance.

According to a VSP Vision Care news release, 71% say they experience performance impacts due to screen-related visual discomfort, equating to nearly one full workday of lost productivity each week.

Tonk, MD, MBA, references updates from TFOS DEWS III that promote standardized screening tools.

For the patient with ocular surface discomfort, cataract surgery becomes a process rather than a single event.

Jade Coats, OD, FAAO, and Cecelia Koetting, OD, FAAO, DipABO, provide a sneak peek into their 2-day session at the conference.

The investigators evaluated the shear-stress-dependent viscous properties of seven commercially available tear formulations. They also studied the viscosity of natural tears.

Keeping a pulse on current developments has helped optometrists look to the future

An overview of the top 10 stories from eye care for 2025.

Isocyclosporin is a dual inhibitor of transient receptor potential cation channel, mucolipin subfamily, member 2 (TRPML2), and calcineurin.

The grading scales were compiled with the goals of achieving conciseness and the ability to provide clear drug-dose-modification recommendations compared with the previous ocular CTCAE scale.

Under the terms of the agreement, Iolyx Therapeutics has granted Théa exclusive worldwide development and commercialization rights, excluding Asia, to ILYX-002 for the treatment of ocular surface diseases.

The survey was conducted by OnePoll on October 2025 and included 1000 US patients with dry eye.

Cyclosporine ophthalmic emulsion 0.05% is a topical immunomodulator to increase tear production in patients whose tear production is thought to be reduced due to ocular inflammation associated with dry eye syndrome.

Rachon, OD, FAAO, DipABO, makes the most of her optometric education through her work with residents and advocacy efforts.

Our patients benefit from a preventive approach that includes lifestyle adjustment, nutrition, and supplementation.

Rose Mandel, OD, shares how the NYU Langone Eye Center tackles a variety of cases in day-to-day practice.

Ensuring proper hydration of the eye takes more moonlight and lullabies.